Cas:41014-20-4 4-(bromomethyl)naphthalene-1-carbonitrile manufacturer & supplier

Chemical Name:4-(bromomethyl)naphthalene-1-carbonitrile

CAS.NO:41014-20-4

Synonyms:1-Naphthalenecarbonitrile,4-(bromomethyl);4-(bromomethyl)-1-naphthonitrile;AB1254;4-BROMOMETHYL-NAPHTHALENE-1-CARBONITRILE;1-bromomethyl-4-cyano-naphthalene;4-(bromomethyl)-1-naphthalenecarbonitrile

Molecular Formula:C₁₂H₈BrN

Molecular Weight:246.10300

HS Code:2926909090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:23.79000

Exact Mass:244.98400

LogP:3.60638

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-Naphthalenecarbonitrile,4-(bromomethyl) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(bromomethyl)-1-naphthalenecarbonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-bromomethyl-4-cyano-naphthalene Use and application,1-bromomethyl-4-cyano-naphthalene technical grade,usp/ep/jp grade.

Related News: The primary endpoint of INSPIRE is overall survival. The trial continued beyond the pre-specified interim analysis and is nearing its conclusion. 4-(bromomethyl)naphthalene-1-carbonitrile manufacturer Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical. 4-(bromomethyl)naphthalene-1-carbonitrile supplier The term active pharmaceutical ingredient may refer to an active chemical within an FDA-regulated drug, or API might mean the entire drug with its active and inactive ingredients. 4-(bromomethyl)naphthalene-1-carbonitrile vendor Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical. 4-(bromomethyl)naphthalene-1-carbonitrile factory The term active pharmaceutical ingredient may refer to an active chemical within an FDA-regulated drug, or API might mean the entire drug with its active and inactive ingredients.